Vardenafil reduces testicular damage following ischemia/reperfusion injury in rats

Kaohsiung J Med Sci. 2009 Jul;25(7):374-80. doi: 10.1016/S1607-551X(09)70530-3.

Abstract

We investigated the effect of intraperitoneal vardenafil (1 mg/kg) administration during an ischemic period in a rat model of testicular torsion/detorsion (T/D). Twenty-one adult Wistar rats were equally randomized into a control group, a T/D group and a vardenafil group. The control group was designed to collect basal values for biochemical and histopathological parameters. The T/D group underwent testicular torsion for 1 hour. The vardenafil group received vardenafil (1 mg/kg) intraperitoneally at 30 minutes after torsion. All rats were sacrificed 4 hours after reperfusion to evaluate the tissue levels of malondialdehyde and total antioxidant status. Germ cell apoptosis was evaluated using the apoptosis protease activating factor 1 antibody in all groups. The expressions of endothelial nitric oxide synthase (NOS) and inducible NOS were also assessed in both testes of all rats. The malondialdehyde levels in the T/D group were significantly higher than in the control and vardenafil groups. There were also significant decreases in total antioxidant status in the T/D group compared with the control and vardenafil groups. Vardenafil treatment significantly reduced apoptosis protease activating factor 1, endothelial NOS and inducible NOS levels in the vardenafil group compared with the T/D group. Administration of 1 mg/kg vardenafil during testicular torsion decreased ischemia/reperfusion cellular damage. Our results indicate that the reduction in oxidative stress by vardenafil may play a major role in its cytoprotective effects.

MeSH terms

  • Animals
  • Antioxidants / metabolism
  • Germ Cells / drug effects
  • Germ Cells / metabolism
  • Germ Cells / pathology
  • Imidazoles* / pharmacology
  • Imidazoles* / therapeutic use
  • Male
  • Malondialdehyde / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Oxidative Stress / drug effects
  • Phosphodiesterase Inhibitors* / pharmacology
  • Phosphodiesterase Inhibitors* / therapeutic use
  • Piperazines* / pharmacology
  • Piperazines* / therapeutic use
  • Rats
  • Rats, Wistar
  • Reperfusion Injury / drug therapy*
  • Reperfusion Injury / physiopathology*
  • Spermatic Cord Torsion / drug therapy
  • Spermatic Cord Torsion / physiopathology*
  • Sulfones / pharmacology
  • Sulfones / therapeutic use
  • Testis / drug effects*
  • Testis / metabolism*
  • Testis / pathology
  • Triazines / pharmacology
  • Triazines / therapeutic use
  • Vardenafil Dihydrochloride

Substances

  • Antioxidants
  • Imidazoles
  • Phosphodiesterase Inhibitors
  • Piperazines
  • Sulfones
  • Triazines
  • Malondialdehyde
  • Vardenafil Dihydrochloride
  • Nitric Oxide Synthase Type II